AstraZeneca boosts cancer portfolio with $320 mln Neogene deal
Nov 29 (Reuters) - AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday,...
Nov 29 (Reuters) - AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday,...